ArticleJournal of gastrointestinal oncology2025

Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical study.

Jie Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.